HomeCompareBPTSY vs PM

BPTSY vs PM: Dividend Comparison 2026

BPTSY yields 444.44% · PM yields 3.48%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BPTSY wins by $25001.19M in total portfolio value
10 years
BPTSY
BPTSY
● Live price
444.44%
Share price
$0.45
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25001.24M
Annual income
$17,330,574,692.45
Full BPTSY calculator →
PM
Philip Morris International
● Live price
3.48%
Share price
$165.34
Annual div
$5.76
5Y div CAGR
17.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$2,492.02
Full PM calculator →

Portfolio growth — BPTSY vs PM

📍 BPTSY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBPTSYPM
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BPTSY + PM cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BPTSY pays
PM pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BPTSY
Annual income on $10K today (after 15% tax)
$37,777.78/yr
After 10yr DRIP, annual income (after tax)
$14,730,988,488.58/yr
PM
Annual income on $10K today (after 15% tax)
$296.12/yr
After 10yr DRIP, annual income (after tax)
$2,118.22/yr
At 15% tax rate, BPTSY beats the other by $14,730,986,370.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BPTSY + PM for your $10,000?

BPTSY: 50%PM: 50%
100% PM50/50100% BPTSY
Portfolio after 10yr
$12500.65M
Annual income
$8,665,288,592.23/yr
Blended yield
69.32%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PM right now

BPTSY
No analyst data
Altman Z
-15.8
Piotroski
1/9
PM
Analyst Ratings
17
Buy
7
Hold
1
Sell
Consensus: Buy
Price Target
$194.30
+17.5% upside vs current
Range: $180.00 — $205.00
Altman Z
4.0
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BPTSY buys
0
PM buys
0
No recent congressional trades found for BPTSY or PM in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBPTSYPM
Forward yield444.44%3.48%
Annual dividend / share$2.00$5.76
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%17.2%
Portfolio after 10y$25001.24M$49.6K
Annual income after 10y$17,330,574,692.45$2,492.02
Total dividends collected$24314.87M$11.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: BPTSY vs PM ($10,000, DRIP)

YearBPTSY PortfolioBPTSY Income/yrPM PortfolioPM Income/yrGap
1← crossover$55,144$44,444.44$11,648$408.29+$43.5KBPTSY
2$288,057$229,052.73$13,589$495.90+$274.5KBPTSY
3$1,426,445$1,118,223.95$15,877$603.21+$1.41MBPTSY
4$6,701,426$5,175,129.87$18,580$734.88+$6.68MBPTSY
5$29,892,686$22,722,160.11$21,781$896.75+$29.87MBPTSY
6$126,709,939$94,724,765.12$25,578$1,096.12+$126.68MBPTSY
7$510,833,781$375,254,145.76$30,092$1,342.17+$510.80MBPTSY
8$1,960,465,947$1,413,873,800.93$35,470$1,646.46+$1960.43MBPTSY
9$7,168,849,807$5,071,151,244.70$41,892$2,023.58+$7168.81MBPTSY
10$25,001,243,986$17,330,574,692.45$49,578$2,492.02+$25001.19MBPTSY

BPTSY vs PM: Complete Analysis 2026

BPTSYStock

Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics targets and activates key biological resilience pathways that can protect against and counteract the effects of the multiple biological and environmental stresses, including inflammatory, oxidative, metabolic, and viral stresses that lead to age-related diseases. The company's lead drug candidate is BIO101, an orally administered small molecule in development to treat neuromuscular diseases, including sarcopenia, Duchenne muscular dystrophy (DMD), and obesity, as well as treatment of severe respiratory failure in patients suffering from COVID-19. It also develops BIO201, an orally administered small molecule for the treatment of retinopathies, including dry age-related macular degeneration, and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its BIO101 for the treatment of DMD. The company was incorporated in 2006 and is headquartered in Paris, France.

Full BPTSY Calculator →

PMConsumer Staples

Philip Morris International Inc. operates as a tobacco company working to delivers a smoke-free future and evolving portfolio for the long-term to include products outside of the tobacco and nicotine sector. The company's product portfolio primarily consists of cigarettes and smoke-free products, including heat-not-burn, vapor, and oral nicotine products that are sold in markets outside the United States. The company offers its smoke-free products under the HEETS, HEETS Creations, HEETS Dimensions, HEETS Marlboro, HEETS FROM MARLBORO, Marlboro Dimensions, Marlboro HeatSticks, Parliament HeatSticks, and TEREA brands, as well as the KT&G-licensed brands, Fiit, and Miix. It also sells its products under the Marlboro, Parliament, Bond Street, Chesterfield, L&M, Lark, and Philip Morris brands. In addition, the company owns various cigarette brands, such as Dji Sam Soe, Sampoerna A, and Sampoerna U in Indonesia; and Fortune and Jackpot in the Philippines. The company sells its smoke-free products in 71 markets. Philip Morris International Inc. was incorporated in 1987 and is headquartered in New York, New York.

Full PM Calculator →
📬

Get this BPTSY vs PM comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BPTSY vs SCHDBPTSY vs JEPIBPTSY vs OBPTSY vs KOBPTSY vs MAINBPTSY vs MOBPTSY vs BTIBPTSY vs PEP

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.